With the introduction of Dihydroartemisinin-piperaquine (DHAP) and artesunate-pyronaridine (ASPY) on the list of anti-malarial drugs available in Rwanda, the number of treatments that can be ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. The idea of antimalarial ...

Edited by Margaret Phillips, The University of Texas Southwestern Medical Center, Dallas, TX; received February 21, 2024; accepted November 24, 2024 ...

The Global Fund to Fight AIDS, Tuberculosis and Malaria, the US President's Malaria Initiative, Unitaid, and the Bill & Melinda Gates Foundation acknowledged in September, 2024, that urgent action is ...

A discredited study that set off a flurry of interest in using an antimalarial drug to treat COVID-19 has now been formally withdrawn. A scientific journal on Tuesday retracted the March 2020 ...

Saman Gunatilake Emeritus Professor of Medicine and Neurologist University of Sri Jayewardenepura Key facts * Substandard and ...

It proved to be particularly important as resistance to other antimalarial drugs such as sulfadoxine-pyrimethamine, mefloquine, halofantrine, and quinine emerged, but in the last few years cases ...

Merck & Co’s immuno-oncology drug Keytruda (pembrolizumab) is projected to be the best-selling drug by annual revenue in 2023, earning $22.2 billion by 2025, according to new research by GlobalData.

Hydroxychloroquine, an antimalarial drug also approved for use in some autoimmune diseases, was first introduced to the world as a potential cure through a March 2020 study of 36 patients with ...

However, long-term steroid treatment can cause severe side effects and force physicians to use various drugs with other mechanisms of action. Antimalarial drugs, such as hydroxychloroquine ...